nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—PSMA1—mouth—autistic disorder	0.0237	0.0652	CbGeAlD
Bortezomib—PSMD1—eye—autistic disorder	0.0126	0.0348	CbGeAlD
Bortezomib—PSMD1—telencephalon—autistic disorder	0.0115	0.0317	CbGeAlD
Bortezomib—PSMD2—eye—autistic disorder	0.0112	0.0308	CbGeAlD
Bortezomib—PSMD2—forebrain—autistic disorder	0.0111	0.0305	CbGeAlD
Bortezomib—PSMA1—digestive system—autistic disorder	0.0105	0.0288	CbGeAlD
Bortezomib—PSMD2—telencephalon—autistic disorder	0.0102	0.0281	CbGeAlD
Bortezomib—PSMB5—telencephalon—autistic disorder	0.00896	0.0247	CbGeAlD
Bortezomib—PSMB1—eye—autistic disorder	0.0086	0.0236	CbGeAlD
Bortezomib—PSMA1—head—autistic disorder	0.00855	0.0235	CbGeAlD
Bortezomib—PSMB2—eye—autistic disorder	0.00839	0.0231	CbGeAlD
Bortezomib—PSMB2—forebrain—autistic disorder	0.00831	0.0229	CbGeAlD
Bortezomib—PSMA1—nervous system—autistic disorder	0.00811	0.0223	CbGeAlD
Bortezomib—PSMB1—telencephalon—autistic disorder	0.00784	0.0216	CbGeAlD
Bortezomib—PSMA1—central nervous system—autistic disorder	0.0078	0.0215	CbGeAlD
Bortezomib—PSMD2—digestive system—autistic disorder	0.00779	0.0214	CbGeAlD
Bortezomib—PSMB2—telencephalon—autistic disorder	0.00765	0.021	CbGeAlD
Bortezomib—PSMA1—cerebellum—autistic disorder	0.00763	0.021	CbGeAlD
Bortezomib—PSMD1—cerebellum—autistic disorder	0.0064	0.0176	CbGeAlD
Bortezomib—PSMD2—head—autistic disorder	0.00636	0.0175	CbGeAlD
Bortezomib—PSMA1—brain—autistic disorder	0.0062	0.017	CbGeAlD
Bortezomib—PSMD2—nervous system—autistic disorder	0.00603	0.0166	CbGeAlD
Bortezomib—PSMB1—digestive system—autistic disorder	0.00598	0.0165	CbGeAlD
Bortezomib—PSMB2—digestive system—autistic disorder	0.00584	0.0161	CbGeAlD
Bortezomib—PSMD2—central nervous system—autistic disorder	0.0058	0.016	CbGeAlD
Bortezomib—PSMD2—cerebellum—autistic disorder	0.00567	0.0156	CbGeAlD
Bortezomib—PSMD1—brain—autistic disorder	0.0052	0.0143	CbGeAlD
Bortezomib—SLC31A1—digestive system—autistic disorder	0.00505	0.0139	CbGeAlD
Bortezomib—PSMB5—cerebellum—autistic disorder	0.00498	0.0137	CbGeAlD
Bortezomib—PSMB1—head—autistic disorder	0.00488	0.0134	CbGeAlD
Bortezomib—PSMB2—head—autistic disorder	0.00476	0.0131	CbGeAlD
Bortezomib—PSMB1—nervous system—autistic disorder	0.00463	0.0127	CbGeAlD
Bortezomib—PSMD2—brain—autistic disorder	0.00461	0.0127	CbGeAlD
Bortezomib—PSMB8—brain—autistic disorder	0.00458	0.0126	CbGeAlD
Bortezomib—PSMB2—nervous system—autistic disorder	0.00451	0.0124	CbGeAlD
Bortezomib—PSMB1—central nervous system—autistic disorder	0.00445	0.0123	CbGeAlD
Bortezomib—PSMB1—cerebellum—autistic disorder	0.00435	0.012	CbGeAlD
Bortezomib—PSMB2—central nervous system—autistic disorder	0.00435	0.012	CbGeAlD
Bortezomib—PSMB2—cerebellum—autistic disorder	0.00425	0.0117	CbGeAlD
Bortezomib—SLC31A1—head—autistic disorder	0.00412	0.0113	CbGeAlD
Bortezomib—PSMB5—brain—autistic disorder	0.00405	0.0111	CbGeAlD
Bortezomib—SLC31A1—nervous system—autistic disorder	0.00391	0.0108	CbGeAlD
Bortezomib—CYP1A1—mouth—autistic disorder	0.00388	0.0107	CbGeAlD
Bortezomib—SLC31A1—central nervous system—autistic disorder	0.00376	0.0104	CbGeAlD
Bortezomib—SLC31A1—cerebellum—autistic disorder	0.00368	0.0101	CbGeAlD
Bortezomib—PSMB1—brain—autistic disorder	0.00354	0.00973	CbGeAlD
Bortezomib—PSMB2—brain—autistic disorder	0.00345	0.00949	CbGeAlD
Bortezomib—CYP2D6—hindbrain—autistic disorder	0.00319	0.00878	CbGeAlD
Bortezomib—SLC31A1—brain—autistic disorder	0.00299	0.00822	CbGeAlD
Bortezomib—PTGS1—forebrain—autistic disorder	0.00215	0.00591	CbGeAlD
Bortezomib—CYP2C19—digestive system—autistic disorder	0.00213	0.00586	CbGeAlD
Bortezomib—PTGS1—telencephalon—autistic disorder	0.00198	0.00543	CbGeAlD
Bortezomib—CYP2D6—brainstem—autistic disorder	0.00183	0.00503	CbGeAlD
Bortezomib—CYP2D6—forebrain—autistic disorder	0.00177	0.00486	CbGeAlD
Bortezomib—CYP1A2—digestive system—autistic disorder	0.00174	0.00479	CbGeAlD
Bortezomib—CYP1A1—digestive system—autistic disorder	0.00172	0.00472	CbGeAlD
Bortezomib—CYP2C9—digestive system—autistic disorder	0.00165	0.00454	CbGeAlD
Bortezomib—CYP2D6—telencephalon—autistic disorder	0.00162	0.00447	CbGeAlD
Bortezomib—PTGS1—digestive system—autistic disorder	0.00151	0.00415	CbGeAlD
Bortezomib—CYP1A1—head—autistic disorder	0.0014	0.00385	CbGeAlD
Bortezomib—CYP1A1—nervous system—autistic disorder	0.00133	0.00365	CbGeAlD
Bortezomib—CYP1A1—central nervous system—autistic disorder	0.00128	0.00352	CbGeAlD
Bortezomib—CYP3A4—digestive system—autistic disorder	0.00126	0.00347	CbGeAlD
Bortezomib—CYP2D6—digestive system—autistic disorder	0.00124	0.00341	CbGeAlD
Bortezomib—PTGS1—head—autistic disorder	0.00123	0.00338	CbGeAlD
Bortezomib—PTGS1—nervous system—autistic disorder	0.00117	0.00321	CbGeAlD
Bortezomib—PTGS1—central nervous system—autistic disorder	0.00112	0.00309	CbGeAlD
Bortezomib—CYP2C8—brain—autistic disorder	0.0011	0.00302	CbGeAlD
Bortezomib—CYP1A1—brain—autistic disorder	0.00101	0.00279	CbGeAlD
Bortezomib—CYP2D6—head—autistic disorder	0.00101	0.00278	CbGeAlD
Bortezomib—CYP3A4—nervous system—autistic disorder	0.000974	0.00268	CbGeAlD
Bortezomib—CYP2D6—nervous system—autistic disorder	0.000959	0.00264	CbGeAlD
Bortezomib—CYP3A4—central nervous system—autistic disorder	0.000938	0.00258	CbGeAlD
Bortezomib—CYP2D6—central nervous system—autistic disorder	0.000923	0.00254	CbGeAlD
Bortezomib—CYP2D6—cerebellum—autistic disorder	0.000902	0.00248	CbGeAlD
Bortezomib—PTGS1—brain—autistic disorder	0.000891	0.00245	CbGeAlD
Bortezomib—CYP2D6—brain—autistic disorder	0.000733	0.00202	CbGeAlD
Bortezomib—PSMB2—Metabolism—PTGS2—autistic disorder	3.03e-05	4.75e-05	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PTGS2—autistic disorder	3.03e-05	4.75e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	3.02e-05	4.75e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IGF1—autistic disorder	3.01e-05	4.73e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—TCN2—autistic disorder	3e-05	4.72e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CACNA1C—autistic disorder	2.99e-05	4.7e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.99e-05	4.7e-05	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PTGS2—autistic disorder	2.98e-05	4.69e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CAT—autistic disorder	2.97e-05	4.67e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—DHFR—autistic disorder	2.97e-05	4.66e-05	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—HRAS—autistic disorder	2.94e-05	4.62e-05	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—HRAS—autistic disorder	2.93e-05	4.6e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—TPH2—autistic disorder	2.92e-05	4.59e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—PTEN—autistic disorder	2.91e-05	4.58e-05	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—HRAS—autistic disorder	2.91e-05	4.57e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—PTEN—autistic disorder	2.9e-05	4.55e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—SERPINE1—autistic disorder	2.9e-05	4.55e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—SERPINE1—autistic disorder	2.9e-05	4.55e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—SERPINE1—autistic disorder	2.9e-05	4.55e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—MAOB—autistic disorder	2.89e-05	4.54e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—PTEN—autistic disorder	2.88e-05	4.53e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.88e-05	4.52e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SLC25A12—autistic disorder	2.87e-05	4.52e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—DPYD—autistic disorder	2.87e-05	4.51e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ADA—autistic disorder	2.86e-05	4.5e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—MAOB—autistic disorder	2.86e-05	4.5e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—SERPINE1—autistic disorder	2.86e-05	4.49e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	2.83e-05	4.45e-05	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—IL6—autistic disorder	2.81e-05	4.42e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PLA2G4A—autistic disorder	2.81e-05	4.41e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—GSTM1—autistic disorder	2.81e-05	4.41e-05	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—IL6—autistic disorder	2.8e-05	4.4e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SLC19A1—autistic disorder	2.8e-05	4.39e-05	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—IL6—autistic disorder	2.79e-05	4.38e-05	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—MAPK1—autistic disorder	2.78e-05	4.36e-05	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—MAPK1—autistic disorder	2.78e-05	4.36e-05	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—MAPK1—autistic disorder	2.78e-05	4.36e-05	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—MAPK1—autistic disorder	2.74e-05	4.3e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.73e-05	4.28e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—DHFR—autistic disorder	2.72e-05	4.28e-05	CbGpPWpGaD
Bortezomib—PSMA1—Disease—HRAS—autistic disorder	2.71e-05	4.26e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	2.71e-05	4.26e-05	CbGpPWpGaD
Bortezomib—PSMD1—Disease—HRAS—autistic disorder	2.7e-05	4.24e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.7e-05	4.24e-05	CbGpPWpGaD
Bortezomib—PSMD2—Disease—HRAS—autistic disorder	2.69e-05	4.22e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—GPX1—autistic disorder	2.69e-05	4.22e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—TPH2—autistic disorder	2.69e-05	4.22e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CACNA1C—autistic disorder	2.67e-05	4.2e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—TPH2—autistic disorder	2.66e-05	4.18e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—DPYD—autistic disorder	2.64e-05	4.15e-05	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PTEN—autistic disorder	2.64e-05	4.15e-05	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—PTEN—autistic disorder	2.64e-05	4.15e-05	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—PTEN—autistic disorder	2.64e-05	4.15e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—DPYD—autistic disorder	2.62e-05	4.12e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—RORA—autistic disorder	2.61e-05	4.1e-05	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PTEN—autistic disorder	2.6e-05	4.09e-05	CbGpPWpGaD
Bortezomib—PSMA1—Disease—IL6—autistic disorder	2.6e-05	4.08e-05	CbGpPWpGaD
Bortezomib—PSMD1—Disease—IL6—autistic disorder	2.59e-05	4.06e-05	CbGpPWpGaD
Bortezomib—PSMD2—Disease—IL6—autistic disorder	2.57e-05	4.04e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.57e-05	4.03e-05	CbGpPWpGaD
Bortezomib—PSMB1—Disease—MAPK1—autistic disorder	2.56e-05	4.03e-05	CbGpPWpGaD
Bortezomib—PSMB5—Disease—MAPK1—autistic disorder	2.56e-05	4.03e-05	CbGpPWpGaD
Bortezomib—PSMB2—Disease—MAPK1—autistic disorder	2.56e-05	4.03e-05	CbGpPWpGaD
Bortezomib—PSMB8—Disease—MAPK1—autistic disorder	2.53e-05	3.97e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.5e-05	3.93e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ADSL—autistic disorder	2.49e-05	3.92e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—MTHFR—autistic disorder	2.48e-05	3.9e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.46e-05	3.86e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CACNA1C—autistic disorder	2.46e-05	3.86e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—MAOB—autistic disorder	2.45e-05	3.85e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—XDH—autistic disorder	2.44e-05	3.84e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CACNA1C—autistic disorder	2.44e-05	3.83e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—DHFR—autistic disorder	2.43e-05	3.82e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—STX1A—autistic disorder	2.4e-05	3.77e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NPAS2—autistic disorder	2.4e-05	3.77e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—MAPK1—autistic disorder	2.37e-05	3.72e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—MAPK1—autistic disorder	2.36e-05	3.7e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IL2—autistic disorder	2.35e-05	3.69e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IL2—autistic disorder	2.35e-05	3.69e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IL2—autistic disorder	2.35e-05	3.69e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—MAPK1—autistic disorder	2.34e-05	3.68e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.34e-05	3.68e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.33e-05	3.66e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CYP19A1—autistic disorder	2.33e-05	3.65e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—TCN2—autistic disorder	2.32e-05	3.64e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IL2—autistic disorder	2.31e-05	3.63e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—APOE—autistic disorder	2.31e-05	3.63e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.29e-05	3.61e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—TPH2—autistic disorder	2.28e-05	3.57e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—DPYD—autistic disorder	2.24e-05	3.52e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—DHFR—autistic disorder	2.23e-05	3.51e-05	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—HRAS—autistic disorder	2.23e-05	3.5e-05	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—HRAS—autistic disorder	2.23e-05	3.5e-05	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—HRAS—autistic disorder	2.23e-05	3.5e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—DHFR—autistic disorder	2.22e-05	3.48e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ADA—autistic disorder	2.21e-05	3.47e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—PTEN—autistic disorder	2.21e-05	3.47e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—PTEN—autistic disorder	2.21e-05	3.47e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—PTEN—autistic disorder	2.21e-05	3.47e-05	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—HRAS—autistic disorder	2.2e-05	3.45e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2.18e-05	3.43e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—PTEN—autistic disorder	2.18e-05	3.42e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—COMT—autistic disorder	2.16e-05	3.4e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GSTP1—autistic disorder	2.15e-05	3.38e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—MAOA—autistic disorder	2.15e-05	3.37e-05	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL6—autistic disorder	2.13e-05	3.35e-05	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL6—autistic disorder	2.13e-05	3.35e-05	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL6—autistic disorder	2.13e-05	3.35e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CYP19A1—autistic disorder	2.13e-05	3.35e-05	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL6—autistic disorder	2.1e-05	3.3e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.1e-05	3.3e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CAT—autistic disorder	2.09e-05	3.29e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PIK3CG—autistic disorder	2.08e-05	3.27e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CACNA1C—autistic disorder	2.08e-05	3.27e-05	CbGpPWpGaD
Bortezomib—PSMB5—Disease—HRAS—autistic disorder	2.06e-05	3.23e-05	CbGpPWpGaD
Bortezomib—PSMB1—Disease—HRAS—autistic disorder	2.06e-05	3.23e-05	CbGpPWpGaD
Bortezomib—PSMB2—Disease—HRAS—autistic disorder	2.06e-05	3.23e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.05e-05	3.22e-05	CbGpPWpGaD
Bortezomib—PSMB8—Disease—HRAS—autistic disorder	2.03e-05	3.19e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—RORA—autistic disorder	2.02e-05	3.17e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2e-05	3.14e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2e-05	3.14e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—POMC—autistic disorder	1.98e-05	3.12e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—COMT—autistic disorder	1.98e-05	3.11e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PLA2G4A—autistic disorder	1.98e-05	3.11e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GSTM1—autistic disorder	1.98e-05	3.11e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GSTP1—autistic disorder	1.97e-05	3.1e-05	CbGpPWpGaD
Bortezomib—PSMB1—Disease—IL6—autistic disorder	1.97e-05	3.09e-05	CbGpPWpGaD
Bortezomib—PSMB5—Disease—IL6—autistic disorder	1.97e-05	3.09e-05	CbGpPWpGaD
Bortezomib—PSMB2—Disease—IL6—autistic disorder	1.97e-05	3.09e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—MAOA—autistic disorder	1.97e-05	3.09e-05	CbGpPWpGaD
Bortezomib—PSMB8—Disease—IL6—autistic disorder	1.94e-05	3.05e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CAT—autistic disorder	1.92e-05	3.02e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CYP19A1—autistic disorder	1.9e-05	2.99e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—HRAS—autistic disorder	1.9e-05	2.99e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GPX1—autistic disorder	1.89e-05	2.97e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—DHFR—autistic disorder	1.89e-05	2.97e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—HRAS—autistic disorder	1.89e-05	2.97e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—MAOB—autistic disorder	1.89e-05	2.97e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—HRAS—autistic disorder	1.88e-05	2.96e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.87e-05	2.93e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—IL6—autistic disorder	1.82e-05	2.86e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PLA2G4A—autistic disorder	1.81e-05	2.85e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GSTM1—autistic disorder	1.81e-05	2.85e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—IL6—autistic disorder	1.81e-05	2.84e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—IL6—autistic disorder	1.8e-05	2.83e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—MAPK1—autistic disorder	1.79e-05	2.82e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—MAPK1—autistic disorder	1.79e-05	2.82e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—MAPK1—autistic disorder	1.79e-05	2.82e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.79e-05	2.81e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—COMT—autistic disorder	1.77e-05	2.78e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—MAPK1—autistic disorder	1.77e-05	2.78e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GSTP1—autistic disorder	1.76e-05	2.77e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—MAOA—autistic disorder	1.76e-05	2.76e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—TPH2—autistic disorder	1.76e-05	2.76e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CYP19A1—autistic disorder	1.75e-05	2.75e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—MTHFR—autistic disorder	1.75e-05	2.75e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GPX1—autistic disorder	1.74e-05	2.73e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CYP19A1—autistic disorder	1.74e-05	2.73e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—DPYD—autistic disorder	1.73e-05	2.71e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CAT—autistic disorder	1.71e-05	2.69e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.63e-05	2.56e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—COMT—autistic disorder	1.63e-05	2.56e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—APOE—autistic disorder	1.63e-05	2.56e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GSTP1—autistic disorder	1.62e-05	2.54e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PLA2G4A—autistic disorder	1.62e-05	2.54e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GSTM1—autistic disorder	1.62e-05	2.54e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—MAOA—autistic disorder	1.62e-05	2.54e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—COMT—autistic disorder	1.61e-05	2.53e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CACNA1C—autistic disorder	1.61e-05	2.52e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GSTP1—autistic disorder	1.61e-05	2.52e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—MTHFR—autistic disorder	1.6e-05	2.52e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—MAOA—autistic disorder	1.6e-05	2.52e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.6e-05	2.51e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTGS2—autistic disorder	1.58e-05	2.49e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CAT—autistic disorder	1.58e-05	2.48e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CAT—autistic disorder	1.56e-05	2.45e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GPX1—autistic disorder	1.55e-05	2.43e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—APOE—autistic disorder	1.49e-05	2.34e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GSTM1—autistic disorder	1.49e-05	2.34e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PLA2G4A—autistic disorder	1.49e-05	2.34e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CYP19A1—autistic disorder	1.48e-05	2.33e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GSTM1—autistic disorder	1.48e-05	2.32e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PLA2G4A—autistic disorder	1.48e-05	2.32e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PIK3CG—autistic disorder	1.47e-05	2.31e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—DHFR—autistic disorder	1.46e-05	2.3e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—HRAS—autistic disorder	1.44e-05	2.26e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—HRAS—autistic disorder	1.44e-05	2.26e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—HRAS—autistic disorder	1.44e-05	2.26e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—MTHFR—autistic disorder	1.43e-05	2.25e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GPX1—autistic disorder	1.43e-05	2.24e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—HRAS—autistic disorder	1.42e-05	2.23e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GPX1—autistic disorder	1.41e-05	2.22e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—POMC—autistic disorder	1.4e-05	2.2e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.39e-05	2.19e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTEN—autistic disorder	1.38e-05	2.17e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IL6—autistic disorder	1.38e-05	2.17e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IL6—autistic disorder	1.38e-05	2.17e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IL6—autistic disorder	1.38e-05	2.17e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—COMT—autistic disorder	1.38e-05	2.17e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GSTP1—autistic disorder	1.37e-05	2.16e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—MAOA—autistic disorder	1.37e-05	2.15e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IL6—autistic disorder	1.36e-05	2.14e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PIK3CG—autistic disorder	1.35e-05	2.11e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CAT—autistic disorder	1.34e-05	2.1e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—APOE—autistic disorder	1.33e-05	2.09e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—MTHFR—autistic disorder	1.32e-05	2.07e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—MTHFR—autistic disorder	1.3e-05	2.05e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—POMC—autistic disorder	1.28e-05	2.01e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PLA2G4A—autistic disorder	1.26e-05	1.98e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GSTM1—autistic disorder	1.26e-05	1.98e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—APOE—autistic disorder	1.22e-05	1.92e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—APOE—autistic disorder	1.21e-05	1.91e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GPX1—autistic disorder	1.21e-05	1.9e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PIK3CG—autistic disorder	1.2e-05	1.89e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYP19A1—autistic disorder	1.14e-05	1.8e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—POMC—autistic disorder	1.14e-05	1.8e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTGS2—autistic disorder	1.11e-05	1.75e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—MTHFR—autistic disorder	1.11e-05	1.75e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PIK3CG—autistic disorder	1.11e-05	1.74e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PIK3CG—autistic disorder	1.1e-05	1.72e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—COMT—autistic disorder	1.06e-05	1.67e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GSTP1—autistic disorder	1.06e-05	1.66e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—MAOA—autistic disorder	1.06e-05	1.66e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—POMC—autistic disorder	1.05e-05	1.65e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—POMC—autistic disorder	1.04e-05	1.64e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—APOE—autistic disorder	1.04e-05	1.63e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CAT—autistic disorder	1.03e-05	1.62e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTGS2—autistic disorder	1.02e-05	1.61e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PLA2G4A—autistic disorder	9.73e-06	1.53e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GSTM1—autistic disorder	9.73e-06	1.53e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTEN—autistic disorder	9.72e-06	1.53e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PIK3CG—autistic disorder	9.36e-06	1.47e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GPX1—autistic disorder	9.32e-06	1.46e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTGS2—autistic disorder	9.12e-06	1.43e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTEN—autistic disorder	8.91e-06	1.4e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—POMC—autistic disorder	8.91e-06	1.4e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—MTHFR—autistic disorder	8.6e-06	1.35e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTGS2—autistic disorder	8.39e-06	1.32e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTGS2—autistic disorder	8.32e-06	1.31e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—APOE—autistic disorder	8.01e-06	1.26e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTEN—autistic disorder	7.96e-06	1.25e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTEN—autistic disorder	7.32e-06	1.15e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTEN—autistic disorder	7.25e-06	1.14e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PIK3CG—autistic disorder	7.22e-06	1.14e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTGS2—autistic disorder	7.11e-06	1.12e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—POMC—autistic disorder	6.88e-06	1.08e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTEN—autistic disorder	6.2e-06	9.74e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTGS2—autistic disorder	5.49e-06	8.62e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTEN—autistic disorder	4.78e-06	7.52e-06	CbGpPWpGaD
